Share

GSK lacking 'focused investment on R&D,' says European pharmaceuticals analyst

Emily Field, head of European pharmaceuticals at Barclays, discusses the various issues at play for GlaxoSmithKline's annual general meeting taking place Wednesday.
02:50
Wed, Jun 23 20218:55 AM EDT